221 related articles for article (PubMed ID: 4827071)
41. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia.
Tollefson G
J Clin Psychopharmacol; 1982 Aug; 2(4):266-70. PubMed ID: 6126494
[No Abstract] [Full Text] [Related]
42. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
43. Procaine in malignant hyperpyrexia.
Moulds RF; Denborough MA
Br Med J; 1972 Dec; 4(5839):526-8. PubMed ID: 4642792
[TBL] [Abstract][Full Text] [Related]
44. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia.
Paasuke RT; Brownell AK
JAMA; 1986 Feb; 255(6):769-71. PubMed ID: 3944979
[TBL] [Abstract][Full Text] [Related]
45. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
[TBL] [Abstract][Full Text] [Related]
46. Malignant hyperpyrexia during anesthesia in childhood.
Bloom DA; Fonkalsrud EW; Reynolds RC
J Pediatr Surg; 1976 Apr; 11(2):185-90. PubMed ID: 1263056
[TBL] [Abstract][Full Text] [Related]
47. Malignant hyperthermia in a family.
Kelstrup J; Haase J; Jorni J; Reske-Nielsen E; Hanel HK
Acta Anaesthesiol Scand; 1973; 17(4):283-4. PubMed ID: 4272689
[No Abstract] [Full Text] [Related]
48. [Examination of the family of a patient susceptible to anesthetic malignant hyperthermia].
Krivosic-Horber R; Theunynck D; Krivosic I; Adnet P; Guévart E
Ann Fr Anesth Reanim; 1986; 5(3):326-9. PubMed ID: 3777561
[TBL] [Abstract][Full Text] [Related]
49. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
Gallant EM; Godt RE; Gronert GA
J Pharmacol Exp Ther; 1980 Apr; 213(1):91-6. PubMed ID: 6965721
[TBL] [Abstract][Full Text] [Related]
50. 'Picture frame' fibres in a carrier of the trait for malignant hyperpyrexia.
Isaacs H; Heffron JJ; Badenhorst M
S Afr Med J; 1975 Nov; 49(46):1923-6. PubMed ID: 795
[TBL] [Abstract][Full Text] [Related]
51. [Peroperative disclosure of a case of malignant hyperthermia. Elements of suspicion of the diagnosis, in vitro study of the sensitivity of muscle fibers].
Brasdefer D; Cantineau D; Tassin M; Krivosic-Horber R; Scherpereel P
Cah Anesthesiol; 1988; 36(2):149-51. PubMed ID: 3365590
[No Abstract] [Full Text] [Related]
52. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
Nelson TE; Bedell DM; Jones EW
Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
[TBL] [Abstract][Full Text] [Related]
53. Is malignant hyperpyrexia muscle denervated?
Moulds RF
J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):975-8. PubMed ID: 591976
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology and inheritance of malignant hyperthermia.
Kalow W; Britt BA; Chan FY
Int Anesthesiol Clin; 1979; 17(4):119-39. PubMed ID: 391720
[No Abstract] [Full Text] [Related]
55. Management of suspected malignant hyperpyrexia in an infant.
Faust DK; Gergis SD; Sokoll MD
Anesth Analg; 1979; 58(1):33-5. PubMed ID: 571220
[TBL] [Abstract][Full Text] [Related]
56. Fulminant malignant hyperthermia.
Bross T; Steinmann D
Acta Anaesthesiol Scand; 2008 Jan; 52(1):164-5. PubMed ID: 18173438
[No Abstract] [Full Text] [Related]
57. Effect of halothane on the rate of acid production, lactate production and pyruvate dehydrogenase activity of malignant hyperpyrexia human muscle.
Bennett D; Cain P; Ellis FR; Halsall J; Louis CF
Br J Anaesth; 1978 Aug; 50(8):799-803. PubMed ID: 678367
[TBL] [Abstract][Full Text] [Related]
58. Histopathological and neuropharmacological aspects of malignant hyperpyrexia.
Ellis FR; Keaney NP; Harriman DG
Proc R Soc Med; 1973 Jan; 66(1 Pt 1):66-7. PubMed ID: 4690061
[No Abstract] [Full Text] [Related]
59. Malignant hyperpyrexia: Investigation of a family after a fatal case.
Ryan DW; Appleyard TN
Br J Anaesth; 1975 Sep; 47(9):1001-4. PubMed ID: 1191461
[TBL] [Abstract][Full Text] [Related]
60. [Screening tests for malignant hyperthermia susceptibility].
Krivosic-Horber R; Adnet P
Ann Fr Anesth Reanim; 1989; 8(5):444-56. PubMed ID: 2560612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
